AERIE PHARMACEUTICALS INC's ticker is AERI and the CUSIP is 00771V108. A total of 175 filers reported holding AERIE PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 1.52 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $6,332,000 | -26.2% | 395,500 | -17.6% | 0.50% | -32.9% |
| Q1 2021 | $8,578,000 | +177.8% | 480,000 | +638.5% | 0.74% | +18.7% |
| Q1 2019 | $3,088,000 | -42.9% | 65,000 | -18.8% | 0.63% | -39.7% |
| Q2 2018 | $5,404,000 | +37.9% | 80,000 | +22.0% | 1.04% | -31.4% |
| Q4 2017 | $3,920,000 | +41.5% | 65,600 | +15.1% | 1.52% | +90.3% |
| Q3 2017 | $2,771,000 | -18.9% | 57,000 | -12.3% | 0.80% | -33.5% |
| Q2 2017 | $3,416,000 | -20.7% | 65,000 | -31.6% | 1.20% | -43.2% |
| Q1 2017 | $4,308,000 | +17.9% | 95,000 | -1.6% | 2.11% | -3.0% |
| Q4 2016 | $3,653,000 | -3.2% | 96,500 | -3.5% | 2.18% | +41.1% |
| Q3 2016 | $3,774,000 | – | 100,000 | – | 1.54% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JACOB ASSET MANAGEMENT OF NEW YORK LLC | 246,563 | $2,244,000 | 1.36% |
| LEVIN CAPITAL STRATEGIES, L.P. | 1,435,876 | $13,066,000 | 1.26% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 4,695,020 | $42,725,000 | 0.96% |
| DCF Advisers, LLC | 189,565 | $1,725,000 | 0.76% |
| DAFNA Capital Management LLC | 289,040 | $2,630,000 | 0.68% |
| RICE HALL JAMES & ASSOCIATES, LLC | 1,678,609 | $15,275,000 | 0.61% |
| Rhenman & Partners Asset Management AB | 589,200 | $5,362,000 | 0.53% |
| PFM Health Sciences, LP | 1,088,566 | $9,906,000 | 0.37% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 309,778 | $2,819,000 | 0.36% |
| Granahan Investment Management | 1,588,944 | $14,459,000 | 0.36% |